OmniSonics Raises $20 Million

OmniSonics Medical Technologies Inc., a Wilmington, Mass.-based developer of ultrasound technology for breaking up blood clots, has raised $20 million in Series D funding, according to VentureWire. Return backers include Canaan Partners, Domain Associates, Johnson & Johnson Development Corp., Nomura Phase4 Ventures, New England Partners, and H&Q Capital Management. The company hopes to add another $15 million to the round from outside investors. OmniSonics has raised over $90 million in total VC funding since its 1998 inception, including a $43 million Series C round at an $88 million post-money valuation.